Embecta Corp (EMBC) reported strong Q4 earnings, exceeding expectations. However, the company announced a restructuring plan, including discontinuing its insulin patch pump program, to improve profitability and reduce debt. This plan is expected to generate significant cost savings, but also impacts revenue projections and delays the Analyst & Investor Day.